
Public Affairs – fostering knowledge transfer between industry and public stakeholders
Our public affairs team aspires to be a leader in responsibility and transparency in the public policy process regarding medicinal cannabis and the cannabis legalization for adult-use.
We are committed to open and transparent discussions that advance the discourse on facts, create a safe and better future for our partners, customers and patients in order to promote trust in the European cannabis industry.
We are proud member of key associations within the cannabis industry, furthering our commitment to excellence and collaboration. As a board member (“Vorstandsmitglied”) of the BPC (Federal Association of Pharmaceutical Cannabinoid Companies), we actively contribute to shaping the voice of pharmaceutical cannabinoid companies in Germany. Furthermore, as a supporting member (“Fördermitglied”) of the VCA (Association of Cannabis Supplying Pharmacies e.V.), we are at the forefront of ensuring quality cannabis care through pharmacies. These partnerships underscore our dedication to leading the industry forward with integrity and expertise.
In addition to our focus on ethical business practices, we prioritize compliance with all relevant laws and regulations in the industry, including registering our lobbying activities and working in accordance with state code of conduct.
Find our latest publications and political letters here.
Press
notices
Keep up to date with the latest news from Cansativa – from product launches and successes to our latest positions on current developments.
25. September 2024
Thanks to Cansativa: Cookies products are now available in Germany!
"Yes, we can Cannabizz" – Berner is coming to Germany on November 14th.
11. June 2024
Cansativa and Cookies team up to bring Cookies products into the German medical cannabis market.
Cansativa Group will exclusively distribute Cookies-branded medical cannabis products across Germany starting 1st of August 2024
30. October 2023
Cansativa and Cronos Group Inc. launch leading medical cannabis brand PEACE NATURALS® in Germany
Cansativa will import, distribute, and market Cronos brand PEACE NATURALS® Frankfurt am Main, 30th of October 2023
Company presentation
to download

CP 2025
PDF-File (3 MB)
Read
our cannabis
Briefing.
Stay up to date on the latest developments in medical cannabis and the legalization process for adult recreational use.
16. April 2026
ICBC Berlin: A Snapshot of the Industry
We attended ICBC Berlin this week, the largest international business trade show in the cannabis industry. Pharmacies, wholesalers, manufacturers,…
2. April 2026
Medicinal Cannabis and Evidence – What the Data Actually Show Today
Medicinal cannabis has been part of routine medical care in Germany since 2017. The available evidence from real-world care data and international…
19. March 2026
Medical Cannabis Dosage Forms – Diversity, Evidence and Regulatory Perspectives
Medical cannabis in Germany is prescribed in a variety of dosage forms. These range from cannabis flower to standardized extracts and approved…
5. March 2026
Medical Cannabis and Telemedicine: Why Medical Autonomy and Clear Rules Matter
One year ago, we looked at the role of telemedicine in the context of medical cannabis. Since then, the debate has gained momentum. At its core lies…
5. February 2026
Cannabis in the United States – Developments, Dynamics, and Lessons
When cannabis regulation is discussed in Germany, attention almost inevitably turns across the Atlantic. For years, the United States has served as a…
22. January 2026
Agenda 2026 – Key Cannabis Events for Medicine, Business and Supply
Trade fairs, conferences and specialist events will once again bring together policymakers, medical professionals, industry representatives and…
8. January 2026
Outlook 2026 – Regulation, Market Developments, and Political Direction in Germany
As 2026 begins, cannabis regulation in Germany is entering its next phase. After a year of hands-on experience with the Cannabis Act, initial…
18. December 2025
The Year 2025 – Cannabis Policy Between Decriminalization and Re-Regulation
As the year draws to a close, it is worth taking a look back at the developments that shaped cannabis policy in Germany in 2025. The new Cannabis Act…
5. December 2025
Could the Medical Cannabis Reform Become a Cost Trap?
The reform of Germany’s medical cannabis system has been on the agenda since the summer. While the debate has so far focused primarily on new hurdles…
21. November 2025
From the Bundesrat to the Bundestag – What Comes Next for the MedCanG Reform
With the upcoming Bundesrat session on 21 November, the legislative process to amend the Medical Cannabis Act (MedCanG) enters a new phase. While the…
Position papers
& Publications
Our position papers address many of the most important issues in our business area. They transparently explain our company position and current assessment on specific topics
Known from
Explore Our Cannabis Briefing
Stay ahead with the latest insights in medical cannabis, political decisions, industry news, and research advances.
Stay informed!
Our newsletter is designed to keep you informed and ahead in the rapidly evolving world of medical cannabis. The Cannabis Briefing is your essential resource for the latest research findings, regulatory updates, market trends, and advocacy efforts shaping the future of cannabis.